HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD Advises Disclosures For Native Advertising Ahead Of FTC Guidance

This article was originally published in The Tan Sheet

Executive Summary

Ads designed to blend in with the platform where it appears can mislead consumers that the material is news content. Firms employing native advertising or sponsored content marketing should disclose their affiliation with external websites or links until FTC releases guidance, attorneys and NAD staffers say.

You may also be interested in...



Supplement Firm Pays $500,000 Redress After Targeting Elderly With Disease Claims

NatureCity will pay $500,000 for consumer redress and contact customers defrauded by claims aloe vera supplements treat high cholesterol, chronic pain and diabetes. Firm promoted AloeCran and TrueAloe supplements with significant promotions and far-reaching direct mailers for nearly 20 years.

'Free Trial' Offers Cost Marketers Of Supplements With Bogus Claims

FTC sends refunds totaling $60,791 to purchasers of Nobetes' product touted as diabetes treatment and $113,000 for purchases of FlexiPrin, a deceptively marketed joint pain supplement. Commission previously settled with both firms.

FTC Commissioners Seem POM-Skeptical In Claims Hearing

“The idea that this company has built these health claims on bogus science is wrong,” says POM Wonderful counsel Edward Lazarus. But commissioners reviewing appeals of FTC’s challenge against POM’s claims for its pomegranate products appeared to believe the company made a number of implied disease claims.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel